CTI BioPharma
$9.1
23
+$0.01+0.06% Friday 19:59
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
1.15B
P/E Ratio
-15.04
Dividend Yield
-
Dividend
-
Earnings
7AugExpected
Expected EPS
-0.08
Actual EPS
N/A
Financials
-172.37%Profit Margin
Unprofitable53.95MRevenue
-92.99MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CTIC. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Pharmaceuticals: Other
Manufacturing
Pharmaceutical Preparation Manufacturing
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.
Show more...
CEO
Adam Craig
Employees
121
Country
US
ISIN
US12648L6011
WKN
000A2DJWX
Listings
0 Comments
Share your thoughts
FAQ
What is CTI BioPharma stock price today?▼
The current price of CTIC is $9.1 USD — it has increased by +0.06% in the past 24 hours. Watch CTI BioPharma stock price performance more closely on the chart.
What is CTI BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CTI BioPharma stocks are traded under the ticker CTIC.
What is CTI BioPharma market cap?▼
Today CTI BioPharma has the market capitalization of 1.15B
What is CTI BioPharma revenue for the last year?▼
CTI BioPharma revenue for the last year amounts to 53.95M USD.
What is CTI BioPharma net income for the last year?▼
CTIC net income for the last year is -92.99M USD.
How many employees does CTI BioPharma have?▼
As of April 02, 2026, the company has 121 employees.
In which sector is CTI BioPharma located?▼
CTI BioPharma operates in the Manufacturing sector.
When did CTI BioPharma complete a stock split?▼
The last stock split for CTI BioPharma was on January 03, 2017 with a ratio of 1:10.
Where is CTI BioPharma headquartered?▼
CTI BioPharma is headquartered in Seattle, US.